secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2023-02-06T23:59:59+00:00
Accession:  0001437749-23-002547
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Labs Q3 revenue -1% to $54.3M; core organic growth 4.6%; net income up 122%
--------------------------------------------------------------------------------

- Revenues $54,287K, down 1% YoY; organic revenue decline 2.1% due to currency and other headwinds.
- Net income $451K ($0.08 diluted EPS) vs $203K in prior year; increase of 122%.
- Non-GAAP AOI excluding unusual items $12,856K (24% of revenue), down 7% YoY.
- Clinical Genomics revenues $15,585K, down 10% organic; core organic growth 3.3% ex-Sema4 would be 19%.
- SDC core organic growth 21.1%; Calibration Solutions impacted by supply chain constraints.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000143774923002547/0001437749-23-002547-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000143774923002547/mlab20230203_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-002547

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer